Growth & profitability
- Revenue has declined 4.9% per year over the past 5 years.
Financial health
- Total debt ($9.7B) exceeds cash ($541M); net debt is $9.2B.
- Total debt has grown faster than revenue (1.8% vs -4.9% per year).
MPT Financials Medical Properties Trust Inc
15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $972M | -$277M | 90.7% | 0.0% | — | $9.7B | $541M |
| 2024 | $996M | -$2.4B | 92.6% | 0.0% | — | $8.8B | $332M |
| 2023 | $872M | -$557M | 87.4% | 0.0% | — | $10.1B | $250M |
| 2022 | $1.5B | $903M | 89.1% | 0.0% | — | $10.3B | $236M |
| 2021 | $1.5B | $656M | 93.4% | 0.0% | — | $11.3B | $459M |
| 2020 | $1.2B | $431M | 97.6% | 0.0% | — | $8.9B | $550M |
| 2019 | $854M | $375M | 80.3% | 0.0% | — | $7.0B | $1.5B |
| 2018 | $785M | $1.0B | 89.3% | 0.0% | — | $4.0B | $821M |
| 2017 | $705M | $290M | 0.0% | 68.9% | — | $4.9B | $171M |
| 2016 | $541M | $225M | 0.0% | 63.1% | — | $2.9B | $83M |
| 2015 | $442M | $140M | 0.0% | 59.6% | — | $3.3B | $196M |
| 2014 | $313M | $51M | 0.0% | 45.7% | — | $2.2B | $145M |
| 2013 | $243M | $97M | 0.0% | 63.3% | — | $1.4B | $46M |
| 2012 | $198M | $90M | 0.0% | 65.5% | — | $1.0B | $37M |
| 2011 | $132M | $27M | 0.0% | 53.0% | — | $690M | $103M |
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $252M | $33M | 61.4% | 0.0% | — | $9.7B | $425M |
| Dec '25 | $270M | $17M | 95.8% | 0.0% | — | $9.7B | $541M |
| Sep '25 | $238M | -$78M | 109.4% | 0.0% | — | $9.6B | $397M |
| Jun '25 | $240M | -$98M | 91.8% | 0.0% | — | $9.6B | $510M |
| Mar '25 | $224M | -$118M | 63.6% | 0.0% | — | $9.5B | $673M |
| Dec '24 | $232M | -$413M | 90.9% | 0.0% | — | $8.8B | $332M |
| Sep '24 | $226M | -$801M | 96.5% | 0.0% | — | $9.2B | $276M |
| Jun '24 | $267M | -$321M | 98.4% | 0.0% | — | $9.4B | $607M |
| Mar '24 | $271M | -$876M | 84.9% | 0.0% | — | $10.1B | $224M |
| Dec '23 | -$122M | -$664M | 41.1% | 0.0% | — | $10.1B | $250M |
| Sep '23 | $307M | $117M | 90.6% | 0.0% | — | $10.2B | $340M |
| Jun '23 | $337M | -$42M | 108.5% | 0.0% | — | $10.2B | $324M |
| Mar '23 | $350M | $33M | 48.0% | 0.0% | — | $10.4B | $302M |
| Dec '22 | $380M | -$140M | 95.8% | 0.0% | — | $10.3B | $236M |
| Sep '22 | $352M | $222M | 99.5% | 0.0% | — | $9.5B | $299M |
| Jun '22 | $400M | $190M | 86.1% | 0.0% | — | $10.1B | $257M |
| Mar '22 | $410M | $632M | 77.1% | 0.0% | — | $10.1B | $249M |
| Dec '21 | $409M | $207M | 91.0% | 0.0% | — | $11.3B | $459M |
| Sep '21 | $391M | $171M | 96.9% | 0.0% | — | $10.6B | $350M |
| Jun '21 | $382M | $115M | 97.2% | 0.0% | — | $10.0B | $721M |
Valuation over time
How the market has priced MPT against its own fundamentals since 2026-02 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-sales ratio has fallen from 3.5× (Feb '26) to 2.7× (Jun '26).
P/S
Frequently asked questions
Is MPT growing its revenue and profit?
Over the past 5 years, Medical Properties Trust Inc's revenue has declined 4.9% per year. These are computed facts, not advice.
How much debt does MPT have?
As of FY2025, Medical Properties Trust Inc reported $9.7B of total debt against $541M of cash.
What is MPT's profit margin?
In FY2025, gross margin was 90.7%, operating margin —, and net margin -28.5%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.